Haisco Pharmaceutical Group Co Ltd

002653

Company Profile

  • Business description

    Haisco Pharmaceutical Group Co Ltd is a pharmaceutical company based in China. It is mainly engaged in the research, development, manufacture, and sale of drugs for liver disease. Its product portfolio includes parenteral nutrition drugs, antibiotics, anesthetic agents, digestive system drugs and tumour adjuvant drug series. The company's products are being used in first rank hospitals in China.

  • Contact

    No. 17, Sanxiang Avenue
    Shannan District
    Tibet Autonomous Region
    Zetang856000
    CHN

    T: +86 8937834865

    http://www.haisco.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    5,337

Stocks News & Analysis

stocks

What does big US court decision mean for Google’s parent company Alphabet?

Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.
stocks

Our only 5-star wide moat ASX share

A difficult year but better times ahead.
stocks

Is this still an ASX share to own forever?

Find out how this defensive player has fared after earnings.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,140.5011.000.12%
CAC 407,656.1042.82-0.56%
DAX 4023,625.66144.67-0.61%
Dow JONES (US)45,316.53304.76-0.67%
FTSE 1009,204.9811.89-0.13%
HKSE25,417.98359.471.43%
NASDAQ21,621.7185.98-0.40%
Nikkei 22543,018.75438.481.03%
NZX 50 Index13,223.5390.330.69%
S&P 5006,464.5837.50-0.58%
S&P/ASX 2008,871.208.600.10%
SSE Composite Index3,812.5146.641.24%

Market Movers